Primary Myelofibrosis
Showing NaN - NaN of 15
Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide
Recruiting
- Primary Myelofibrosis
- +2 more
- Pacritinib
- Physician's Choice medications
-
Birmingham, Alabama
- +151 more
Aug 22, 2022
Myeloproliferative Disorders, Myelofibrosis, Primary Myelofibrosis Trial in Worldwide (ACE-536, Placebo)
Recruiting
- Myeloproliferative Disorders
- +4 more
- ACE-536
- Placebo
-
La Jolla, California
- +184 more
Aug 22, 2022
Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post- Essential Thrombocythemia Myelofibrosis Trial in Worldwide
Completed
- Primary Myelofibrosis
- +2 more
-
Phoenix, Arizona
- +61 more
May 5, 2022
Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide
Terminated
- Primary Myelofibrosis
- +2 more
- Pacritinib
- Best Available Therapy
-
Scottsdale, Arizona
- +121 more
Oct 21, 2021
Primary Myelofibrosis, Post-Polycythemia Vera, Post-Essential Thrombocytopenia Trial in United States (Panobinostat)
Terminated
- Primary Myelofibrosis
- +2 more
-
Scottsdale, Arizona
- +8 more
Jul 9, 2021
Acute Megakaryoblastic Leukemia, Myelofibrosis, Primary Myelofibrosis Trial in Miami, Chicago, Rochester (Alisertib, Laboratory
Active, not recruiting
- Acute Megakaryoblastic Leukemia
- +2 more
- Alisertib
- +2 more
-
Miami, Florida
- +2 more
May 4, 2021
Connect® Myeloid Disease Registry
Recruiting
- Primary Myelofibrosis
- +2 more
-
Huntsville, Alabama
- +228 more
Mar 30, 2021
Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary Myelofibrosis Trial in Chicago (Durvalumab, Laboratory
Withdrawn
- Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
- Primary Myelofibrosis
- Durvalumab
- Laboratory Biomarker Analysis
-
Chicago, IllinoisNorthwestern University
Aug 16, 2019
Primary Myelofibrosis, MPN-associated Myelofibrosis Trial in Worldwide (Pomalidomide 0.5 mg, Placebo, Pomalidomide)
Completed
- Primary Myelofibrosis
- MPN-associated Myelofibrosis
- Pomalidomide 0.5 mg
- +2 more
-
Scottsdale, Arizona
- +86 more
Jun 24, 2019
Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis Trial in Canada,
Terminated
- Primary Myelofibrosis
- +2 more
- Ruxolitinib Pre- Hematopoietic cell transplantation (HCT)
-
Atlanta, Georgia
- +7 more
Feb 28, 2019
Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +84 more
- sunitinib malate
- +2 more
-
Los Angeles, California
- +10 more
Mar 14, 2014
Chronic Myelomonocytic Leukemia, Essential Thrombocythemia, Polycythemia Vera Trial in Chicago (imatinib mesylate, laboratory
Completed
- Chronic Myelomonocytic Leukemia
- +3 more
- imatinib mesylate
- laboratory biomarker analysis
-
Chicago, IllinoisUniversity of Chicago
Feb 24, 2014